Enterprise Stent Aneurysm Treatment (ESAT) Study - France
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jonathan Megerian, MD, PhD
Codman & Shurtleff
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Amiens
Amiens, France
- Jean Minjoz Hospital
Besançon, France
- Pellegrin Hospital
Bordeaux, France
- Albert Michallon Hospital
Grenoble, France
- Roger Salengro Hospital
Lille, France
- Timone Hospital
Marseille, France
- Beaujon Hospital
Paris, France
- la Pitie Salpetiere Hospital
Paris, France
- la Pitie Salpetriere Hospital
Paris, France
- Lariboisiere Hospital
Paris, France
- Pitie Salpetriere Hospital
Paris, France
- Rothschild Foundation
Paris, France
- White House Hospital
Reims, France
- Purpan Hospital
Toulouse, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2009
- Primary completion
- 31 Aug 2013
- Completion
- 31 Aug 2013
- Last update posted
- 11 Oct 2013
- Registered enrollment
- 133
- Registry id
- NCT00879580
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.